Provided by Tiger Trade Technology Pte. Ltd.

Mainz Biomed B.V.

0.5916
-0.0181-2.97%
Pre-market: 0.61450.0229+3.87%08:49 EST
Volume:126.16K
Turnover:73.30K
Market Cap:5.36M
PE:-0.07
High:0.6101
Open:0.6000
Low:0.5511
Close:0.6097
52wk High:6.29
52wk Low:0.5511
Shares:9.06M
Float Shares:9.01M
Volume Ratio:0.07
T/O Rate:1.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.3903
EPS(LYR):-22.3610
ROE:-465.82%
ROA:-114.35%
PB:2.12
PE(LYR):-0.03

Loading ...

Company Profile

Company Name:
Mainz Biomed B.V.
Exchange:
NASDAQ
Establishment Date:
2008
Employees:
23
Office Location:
Robert Koch Strasse 50,Mainz,Rhineland-Palatinate,Germany
Zip Code:
55129
Fax:
- -
Introduction:
Mainz Biomed N.V. develops and sells in-vitro diagnostic tests for the early detection of cancer in the United States. The company offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. It also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. The company was founded in 2008 and is based in Mainz, Germany.

Directors

Name
Position
Guido Baechler
Chief Executive Officer, Director
Moritz Eidens
Chief Science Officer, Director
Alberto Libanori
Director
Hans Hekland
Director
Marco Messina
Director
Nicole Holden
Director

Shareholders

Name
Position
Guido Baechler
Chief Executive Officer, Director
Philipp Freese
Chief Operating Officer
William Caragol
Chief Financial Officer
Moritz Eidens
Chief Science Officer, Director